Changes in insulin therapy regimens over 10yr in children and adolescents with type 1 diabetes attending diabetes camps

Pediatric Diabetes

Volumn 15, Issue 5, 2014, Pages 329-335

  Redon, Isabelle ^a   Beltrand, Jacques ^a,b   Martin, Delphine ^a   Taupin, Pierre ^a   Choleau, Carine ^c   Morandini, Mélina ^a   Cahané, Michel ^c   Robert, Jean Jacques ^a,b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Centre d'Éducation Thérapeutique   (France)

Author keywords

Adolescents; Children; Glycemic control (HbA1c); Insulin therapeutic regimen; Type 1 diabetes

Indexed keywords

BIPHASIC INSULIN; HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; LONG ACTING INSULIN; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ARTICLE; BOLUS INJECTION; CHILD; CORRELATION ANALYSIS; FEMALE; FRANCE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; METABOLISM; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN, LONG-ACTING; MALE; YOUNG ADULT;

EID: 84904462702     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12062     Document Type: Article

References (38)

1. Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2004: CD003287.
2. Deeb LC, Holcombe JH, Brunelle R et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics 2001: 108: 1175-1179.
3. Tupola S, Komulainen J, Jaaskelainen J, Sipila I. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with type 1 diabetes mellitus. Diabet Med 2001: 18: 654-658.
4. Holcombe JH, Zalani S, Arora VK, Mast CJ. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents. Clin Ther 2002: 24: 629-638.
5. Ford-Adams ME, Murphy NP, Moore EJ et al. Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus. Diabet Med 2003: 20: 656-660.
6. Mohn A, Strang S, Wernicke-Panten K, Lang AM, Edge JA, Dunger DB. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care 2000: 23: 557-559.
7. Alemzadeh R, Berhe T, Wyatt DT. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycaemia among pre-school-aged children with type 1 diabetes mellitus. Pediatrics 2005: 115: 1320-1324.
8. Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J. Insulin detemir compared with NPH insulin in children and adolescents with type 1 diabetes. Diabet Med 2007: 24: 27-34.
9. De Beaufort CE, Houtzagers CM, Bruining GJ et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989: 6: 766-771.
10. Bougnères PF, Landais P, Mairesse AM et al. Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter controlled study. Diabetes Care 1993: 16: 94-102.
11. DCCT Research Group. Effect on intensive diabetes treatment of diabetes on the development and progression of long-term complications in adolescents with insulin dependent diabetes mellitus: Diabetes control and complications trial. J Pediatr 1994: 125: 177-188.
12. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554-1558.
13. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007: 30: 1653-1662.
14. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and metaanalysis of randomized control trials. Pediatr Diabetes 2009: 10: 52-58.
15. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycemic control in young people with type-1 diabetes in Scotland: a population-based study (DIABAUD2). Diabetes Care 2001: 24: 239-244.
16. Mortensen HB, Villumsen J, Volund AA, Petersen KE, Nerup J and the Danish Study Group of Diabetes in Childhood. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. Diabet Med 1992: 9: 834-839.
17. Tubiana-Rufi Moret L, Chwalow J, Czernichow P, et le groupe collaboratif PEDIAB. Etat de santé et facteurs liés au contrôle glycémique chez 165 enfants atteints de diabète insulino-dépendant âgés de 7 à 13 ans. Arch Pediatr 1994: 1: 982-990.
18. Dorchy H, Roggemans MP, Willems D. Glycated haemoglobin and related factors in diabetic children and adolescents under 18years of age: a Belgian experience. Diabetes Care 1997: 20: 2-6.
19. Mortensen HB, Hougaard P, the Hvidoere Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2, 873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997: 20: 714-720.
20. Mortensen HB, Hartling S, Petersen KE, the Danish Study Group of Diabetes in Childhood. A nationwide cross-sectional study of glycosylated haemoglobin in Danish children with type 1 diabetes. Diabet Med 1998: 5: 871-876.
21. Rosilio M, Cotton JB, Wieliczko MC et al., the French Pediatric Diabetes Group. Factors associated with glycemic control. A cross-sectional nationwide study in 2579 French children with type 1 diabetes. Diabetes care 1998: 21: 1146-1153.
22. Vanelli M, Chiarelli F, Chiari G et al. Metabolic control in children and adolescents with diabetes. J Pediatr Endocrinol Metab 1999: 12: 403-409.
23. Danne T, Mortensen HB, Hougaard P, the Hvidoere Study Group on Childhood Diabetes et al. Persistent differences among centres over 3years in glycemic control and hypoglycemia in a study of 3, 805 children and adolescents with type 1 diabetes. Diabetes Care 2001: 24: 1342-1347.
24. Holl RW, Swift PG, Mortensen HB, Lynggard H, Hougaard P et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3years: results from the Hvidoere Study Group. Eur J Pediatr 2003: 162: 22-29.
25. De Beaufort C, Swift P, Skinner C, the Hvidoere Study Group on Childhood Diabetes et al. Continuing stability of centre differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? Diabetes Care 2007: 30: 2245-2250.
26. Gerstl EM, Rabl W, Rosenbauer J et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27, 035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 2008: 167: 447-453.
27. Kappelen TM, Wolf J, Rosenbauer J et al, the DPV-Science-Initiative. Changes in the use of analogue insulins in 37206 children and adolescents with type 1 diabetes in 275 German and Austrian centers during the last twelve years. Exp Clin Endocrinol Diabetes 2009: 117: 329-335.
28. Lievre M, Marre M, Robert JJ et al. on behalf of the Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus. Diabetes Metab 2005: 31: 41-46.
29. Jeitler K, Horvath K, Berghold A et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008: 51: 941-951.
30. Bangstad HJ, Danne T, Deeb LC et al. Insulin treatment in children and adolescents with diabetes. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium. Pediatr Diabetes 2009: 10 (Suppl. 2): 82-99.
31. Swift PGF (Ed). The management of type 1 diabetes in children and adolescents. In: ISPAD Consensus Guidelines. Zeist, The Netherlands: Publ Medforum, 2000.
32. Commission Pédagogique de l'AJD. Les Cahiers de l'AJD: Education au début du diabète de type 1. Les Editions de l'AJD, Paris
33. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br Med J 2002: 324: 1-6.
34. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003: 26: 1079-1087.
35. Sulmont V, Souchon PF, Gouillard-Darnaud C et al. Metabolic control in children with diabetes mellitus who are younger than 6years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? J Pediatr 2010: 157: 103-107.
36. Martin D, Taupin P, Bouchetata M, Fermanian J, Robert JJ; AJD Educative Committee. Validation of a questionnaire of knowledge for type 1 diabetes children and adolescents and their parents. In: 34th Annual Meeting of ISPAD, Durban, August 2008.
37. Hirsch IB, Farkas-Hirsch R, Skyler JS. Intensive insulin therapy for treatment of type 1 diabetes. Diabetes Care 1990: 13: 1265-1283.
38. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.